TRACON

TRACON Pharmaceuticals is dedicated to addressing patients with sarcoma and inadequate treatment options. The company is sponsoring the ENVASARC pivotal trial of the subQ PD-L1 antibody envafolimab in patients with refractory sarcoma UPS and MFS.